While DENTSPLY Sirona Inc has underperformed by -0.07%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, XRAY fell by -24.50%, with highs and lows ranging from $27.48 to $12.16, whereas the simple moving average fell by -13.34% in the last 200 days.
On April 15, 2025, Morgan Stanley Downgraded DENTSPLY Sirona Inc (NASDAQ: XRAY) to Equal-Weight. A report published by Needham on March 13, 2025, Downgraded its rating to ‘Hold’ for XRAY. Wells Fargo also rated XRAY shares as ‘Equal Weight’, setting a target price of $20 on the company’s shares in an initiating report dated February 14, 2025. Jefferies January 23, 2025d the rating to Hold on January 23, 2025, and set its price target from $30 to $20. Evercore ISI January 07, 2025d its ‘Outperform’ rating to ‘In-line’ for XRAY, as published in its report on January 07, 2025. Mizuho’s report from December 04, 2024 suggests a price prediction of $21 for XRAY shares, giving the stock a ‘Neutral’ rating. Leerink Partners also rated the stock as ‘Market Perform’.
Analysis of DENTSPLY Sirona Inc (XRAY)
A return on investment can be expected regardless of XRAY’s performance over the next quarter with the dividend set at $0.64 per share. Further, the quarter-over-quarter decrease in sales is -4.88%, showing a negative trend in the upcoming months.
To gain a thorough understanding of DENTSPLY Sirona Inc’s future performance, several well-rounded types of analysis and research techniques can be used, with equity being among the most crucial. The goal here is to ensure that your current return on equity of -37.78% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 1.11, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.
It is also very valuable to look at average volume as an indicator of volatility for a stock, and XRAY is recording an average volume of 3.03M. On a monthly basis, the volatility of the stock is set at 4.03%, whereas on a weekly basis, it is put at 2.79%, with a gain of 0.49% over the past seven days. Furthermore, long-term investors anticipate a median target price of $16.58, showing growth from the present price of $14.33, which can serve as yet another indication of whether XRAY is worth investing in or should be passed over.
How Do You Analyze DENTSPLY Sirona Inc Shares?
The number of employees owning shares of the company should also be considered in addition to the fundamentals. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 0.64%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 101.84% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
